Fresenius Medical Care AG & Co. KGaA postpones 2020 Annual General Meeting
DGAP-News: Fresenius Medical Care AG & Co. KGaA
/ Key word(s): AGM/EGM
As soon as conditions allow again for a reliable planning and safe implementation of the Annual General Meeting, Fresenius Medical Care will announce the new date.
Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: "The decision to postpone our Annual General Meeting was not an easy one for us to take. But the protection and health of our shareholders and employees is very important to us. In light of this exceptional situation, a postponement is the only sensible option."
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,994 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 345,096 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the Company's website at www.freseniusmedicalcare.com.
Dr. Dominik Heger
Head of Investor Relations, Strategic Development & Communications I EVP
Tel. +49 6172 609 2525
30.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Company:||Fresenius Medical Care AG & Co. KGaA|
|61352 Bad Homburg|
|Phone:||+49 (0) 6172- 609 2525|
|Fax:||+49 (0) 6172- 609 2301|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange|
|EQS News ID:||1010023|
|End of News||DGAP News Service|